Skip to Main Content

The post below is adapted from a STAT Report, “Democrats and drug pricing,” a deeply reported examination of how the 2020 presidential candidates could reshape the pharmaceutical industry. You can access the full version here

President Trump has made drug pricing a key policy tenet of his three-year tenure in the White House. And as his drug pricing policy has grown more aggressive in the past year, his Democratic challengers in the 2020 election have responded in kind.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!